Valsartan-hctz 160-12.5 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB25FH0W7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,635
Award facts
- Contract value 100% obligated
- $8,635.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a quantity of 90 units, with a contract value of $8,635.00. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Department of Defense medical supply chain, delivering a comprehensive range of medications and medical supplies to support military healthcare programs. This specific delivery order for a cardiovascular medication reflects the company's role in providing generic pharmaceutical products across multiple therapeutic domains to federal healthcare systems, including the Defense Health Agency and other government medical procurement needs. The competitive award demonstrates AmerisourceBergen's capability to meet federal procurement requirements through its established relationship with the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FH0W7?
SPE2DB25FH0W7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FH0W7 worth?
The government has obligated $8,635 on SPE2DB25FH0W7.
Is contract SPE2DB25FH0W7 an order under another contract?
Yes. SPE2DB25FH0W7 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH0W7 competed?
The extent of competition for SPE2DB25FH0W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award